About
Technology
Issues
FAQ
Title
Abstract
Text
Figure Captions
Table Cells
Section Titles
Keywords
Subjects
Authors
From
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
To
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1995
1990
1985
1980
1975
1970
1960
1950
1940
1930
1920
1910
1900
1850
1800
1700
1600
All Types
Articles
Communications
Reviews
Discussions
Case Reports
Chapters
Books
News
Editorials
Order By
Order By Year ASC
Order By Year DESC
Order By Citations ASC
Order By Citations DESC
Go
Scientometrics
Impact Factor
Discipline Ranks
H-Index
G-Index
Articles
Citations
Article Citations
Citation Distribution
Search This Journal
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
exaly
›
Journals
›
Journal of Acquired Immune Deficiency Syndromes (1999)
›
Top Articles
Journal of Acquired Immune Deficiency Syndromes (1999)
Pharmacology
3.1
(top 5%)
Impact Factor
3.4
(top 5%)
extended IF
156
(top 2%)
H-Index
3.5K
authors
9K
papers
248.4K
citations
6.5K
citing journals
48K
citing authors
Most Cited Articles of Journal of Acquired Immune Deficiency Syndromes (1999)
Title
Year
Citations
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study
2006
1.1K
Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs
2005
997
Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission
2002
666
Depression and HIV/AIDS treatment nonadherence: a review and meta-analysis
2011
511
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
2002
505
The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics
2004
442
Coronary heart disease in HIV-infected individuals
2003
403
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group
2012
394
Comparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras
2006
379
Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study
2007
364
Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection
2001
364
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals
2009
359
Alcohol use and antiretroviral adherence: review and meta-analysis
2009
357
Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature
2002
353
Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection?
2002
334
Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission
2004
330
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals
2006
324
Hyperlipidemia and Insulin Resistance Are Induced by Protease Inhibitors Independent of Changes in Body Composition in Patients With HIV Infection
2000
320
Barriers to antiretroviral adherence for patients living with HIV infection and AIDS in Botswana
2003
316
Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection
2004
312
Trust and the acceptance of and adherence to antiretroviral therapy
2001
307
Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients
2002
300
Predictors of Self-Reported Adherence and Plasma HIV Concentrations in Patients on Multidrug Antiretroviral Regimens
2000
300
Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa
2009
293
Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: recommendations of an International AIDS Society-USA panel
2002
293
previous
2004
2005
2006
How are inpact factors calculated?
The impact factor (IF) is calculated by counting citations from peer-reviewed journals only.
extended IF
also counts citations from books and conference papers. However, no patent, abstract, working papers, online documents, etc., are covered.
site/software ©
exaly
; All materials licenced under
CC by-SA
.